A longitudinal study of rotenone-induced Parkinsonism in mice
Abstract
Parkinson’s disease (PD) is a progressive neurodegenerative disorder characterized by the loss of dopaminergic neurons in the substantia nigra. Environmental toxins such as rotenone are widely used to model PD pathology and evaluate new drugs in PD; however, the long-term consequences of toxin exposure remain poorly understood. Here, we performed a longitudinal mouse study to examine the onset, progression, and long-term outcomes of rotenone-induced PD-like phenotypes. A 21-day regimen of rotenone (2.5 mg/kg/day, intraperitoneal) produced robust Parkinsonism-like phenotypes by week 4, including impaired locomotion, anxiety-like behaviors, and deficits in motor coordination and learning, accompanied by reduced tyrosine hydroxylase (TH) expression and loss of TH+ neurons in the substantia nigra pars compacta. Unexpectedly, these behavioral and neuropathological deficits gradually resolved over time. After 12 months of toxin cessation, rotenone-treated mice exhibited behavioral performance and TH expression levels comparable to untreated controls. These findings reveal a previously underappreciated capacity for adaptive resilience within the nigrostriatal dopaminergic system following toxic injury.
Related
- Modelling prodromal Parkinson's disease- gastrointestinal pathology and early motor deficits in mice after transient rotenone exposure
- Emergence of Task-Related Motor Cortical Dysfunction in Mice with Progressive Parkinsonism
- Repeated exposure to viral and bacterial danger signals in Parkin deficient mice induces inflammation but fails to trigger parkinsonism
- Effects of Cyperus Esculentus Infused Diet on the Hippocampus in Rotenone-Induced Parkinson-like Disease Model in adult male Wistar Rats; a preliminary study.
- Muscle stem cell treatment mitigates stress-associated multiorgan dysfunction in D-galactose-induced accelerated aging mice and improves behavior in naturally aged mice
BibTeX
@article{joshi2026longitudinal,
title = {{A longitudinal study of rotenone-induced Parkinsonism in mice}},
author = {Prince Joshi and Fan Fan and Xuelin Lou},
journal = {iScience},
year = {2026},
month = oct,
doi = {10.1016/j.isci.2026.117996},
url = {https://www.cell.com/iscience/fulltext/S2589-0042(26)03379-1},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - A longitudinal study of rotenone-induced Parkinsonism in mice
AU - Prince Joshi
AU - Fan Fan
AU - Xuelin Lou
PY - 2026
DA - 2026/10/23
JO - iScience
DO - 10.1016/j.isci.2026.117996
UR - https://www.cell.com/iscience/fulltext/S2589-0042(26)03379-1
AB - Parkinson’s disease (PD) is a progressive neurodegenerative disorder characterized by the loss of dopaminergic neurons in the substantia nigra. Environmental toxins such as rotenone are widely used to model PD pathology and evaluate new drugs in PD; however, the long-term consequences of toxin exposure remain poorly understood. Here, we performed a longitudinal mouse study to examine the onset, progression, and long-term outcomes of rotenone-induced PD-like phenotypes. A 21-day regimen of rotenone (2.5 mg/kg/day, intraperitoneal) produced robust Parkinsonism-like phenotypes by week 4, including impaired locomotion, anxiety-like behaviors, and deficits in motor coordination and learning, accompanied by reduced tyrosine hydroxylase (TH) expression and loss of TH+ neurons in the substantia nigra pars compacta. Unexpectedly, these behavioral and neuropathological deficits gradually resolved over time. After 12 months of toxin cessation, rotenone-treated mice exhibited behavioral performance and TH expression levels comparable to untreated controls. These findings reveal a previously underappreciated capacity for adaptive resilience within the nigrostriatal dopaminergic system following toxic injury.
SN - 2589-0042
ER -